BioBusiness

Articles

The European Commission has granted marketing authorization to Incyte and MorphoSys for Minjuvi (tafasitamab) in combination therapy with lenalidomide to treat relapsed or refractory DLBCL.

Incyte and MorphoSys Receive EC Approval for Minjuvi in Combination Therapy for Lymphoma

Eli Lilly and Company and industry partners, including Ziath, are focused on speeding up the drug discovery process with a fully automated lab.

Next-Gen Automation Lab Aims to Speed Up Drug Discovery Process

Merck KGaA has partnered with Telix Pharmaceuticals to conduct combination clinical studies for cancer therapy.

Merck KGaA and Telix Partner on Pan-Cancer Clinical Combination Studies

Lykan Bioscience and Vineti will combine their capabilities to streamline process development and manufacturing to move cell therapies through clinical phases to commercialization.

Lykan Bioscience and Vineti Partner to Advance Cell Therapies from Clinic to Commercialization

A collaboration between Aldevron and Ginkgo Bioworks has resulted in a manufacturing enhancement that can improve production of an enzyme used for mRNA therapeutics.

Aldevron and Ginkgo Bioworks Collaboration Yields mRNA Manufacturing Enhancement

Lonza and Sheba Medical Center have successfully dosed four patients with a CD19 autologous CAR-T cell therapy using Lonza’s Cocoon automated manufacturing platform.

Lonza and Sheba Medical Center Demonstrate Successful Cell Therapy Results with Cocoon Automated Platform

Nanoform and Boehringer Ingelheim have executed a master services agreement in relation to pre-clinical development projects.

Nanoform, Boehringer Ingelheim Collaborate on Pre-Clinical Development Projects

A research collaboration will combine Imugene’s oncolytic virus technology with Celularity’s allogeneic CAR T-cell therapy.

Imugene and Celularity to Develop Solid Tumor Treatment

Samsung Biologics and Kineta have entered into a strategic partnership for drug product manufacturing services and to support an IND filing of a novel antibody therapeutic. 

Samsung Biologics Partners with Kineta for Anti-VISTA Antibody Immunotherapy

Cellares has entered into a strategic relationship with Poseida Therapeutics to advance a closed, automated, and scalable cell therapy manufacturing system.

Partnerships